Camp4 Therapeutics Corporation announced that it has entered into a First Amendment to its existing lease agreement with ARE-MA Region No. 59, LLC for its Cambridge, Massachusetts premises. The amendment accelerates the termination date of the Cambridge lease to thirty days after the commencement of a new Watertown lease. Under the terms of the amendment, base rent for the Cambridge premises will be abated from October 1, 2025, through the early termination date, provided there is no default under either lease. In consideration for the amendment, Camp4 Therapeutics will pay a lease modification fee of approximately $2.1 million in monthly increments. Additionally, the company’s base rent obligation under the Watertown lease will be further abated for a period covering the first 14 months after the rent commencement date, subject to certain conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001736730-25-000116), on December 23, 2025, and is solely responsible for the information contained therein.